HBV Immune-Therapy: From Molecular Mechanisms to Clinical Applications

Chronic hepatitis B virus (HBV) infection represents a worldwide public health concern with approximately 250 million people chronically infected and at risk of developing liver cirrhosis and hepatocellular carcinoma. Nucleos(t)ide analogues (NUC) are the most widely used therapies for HBV infection...

Descripción completa

Detalles Bibliográficos
Autores principales: Boni, Carolina, Barili, Valeria, Acerbi, Greta, Rossi, Marzia, Vecchi, Andrea, Laccabue, Diletta, Penna, Amalia, Missale, Gabriele, Ferrari, Carlo, Fisicaro, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600394/
https://www.ncbi.nlm.nih.gov/pubmed/31195619
http://dx.doi.org/10.3390/ijms20112754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600394/
https://www.ncbi.nlm.nih.gov/pubmed/31195619
http://dx.doi.org/10.3390/ijms20112754

Ejemplares similares